Gestational Diabetes Mellitus studies

The prevalence of gestational diabetes mellitus is influenced by the race or ethnicity, age, and obesity among women in the delivery population as well as the criteria used to make the diagnosis. Our researchers study the causes, genetics, treatment, and outcomes of women with gestational diabetes and their children.

Air Pollution and Pregnancy Complications in Complex Urban Environments: Risks, Heterogeneity, and Mechanisms (APPCUE)

To advance the understanding of the impact of air pollutant mixture and the built environment on pregnancy complications (gestational diabetes, gestational hypertension, and pre-eclampsia/eclampsia) and outcomes by leveraging prospectively- recorded and high-quality maternal clinical data from the electronic health record and address data with state-of-the-art spatiotemporal air pollution modeling and novel statistical methods that examine both individual and composite exposure profiles.

Principal Investigator:

Darios Getahun, MD, PhD, MPH

Funding Source:

National Institute of Environmental Health Sciences (NIEHS)

Funding Years:

2019 - 2023

Effects of air pollution and gestational diabetes on autism

The proposal will gather preliminary biomarker data in newborns in response to air pollution and gestational diabetes exposure in-utero

Principal Investigator:

Anny Hui Xiang, PhD, MS

Funding Source:

Not Applicable

Funding Years:

2017

The Virtual Visit for Women with Gestational Diabetes Mellitus (GDM)

This pilot study will address two specific aims: (1) to assess the acceptability of telemedicine technology to conduct virtual office visits alternating with regular office- based prenatal visits for women with GDM from the viewpoint of women with GDM and their health care providers using qualitative research methods, and (2) to assess the feasibility of this telemedicine-based intervention (Virtual Office Visit) for women with GDM. This information was be used to support a larger proposal to obtain funding to conduct a clinical trial to test the proposed intervention after it is refined based on input from patients and health care providers.

Principal Investigator:

David A. Sacks, MD

Funding Source:

Kaiser Permanente, Southern California

Funding Years:

2014